John Matsoukas,Michael Maragoudakis,Dimitrios Vlaxakos
申请号:
US12601402
公开号:
US08563586B2
申请日:
2008.05.23
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention provides novel 1,5 and 1,3,5-substituted imidazole compounds in hydrophilic or lipophilic form, which are useful as angiotensin II ATI receptor antagonists suitable for transdermal delivery. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases.